Gexval
2-26-1 Muraoka Higashi, Shonan iPark, Fujisawa-shi, Kanagawa, 251-8555, Japan
Overview
Jexval is a drug-discovery startup focused on developing treatments for intractable and rare diseases. The company is led by Representative Director Shuran Kato and is based in Fujisawa, Kanagawa. In December 2023 it announced a third-party allocation of shares to raise capital. The raise is intended to accelerate development activities in Australia and to add programs to its development pipeline. The announcement was published via PR Times on December 4, 2023. No operating metrics (revenue/users) or past financings were specified in the article.
- Total raised
- $3M
- Funding rounds
- 1
- Latest round
- Equity
- Latest activity
- Jan 2023
Industries
- Emergency Medicine
- Health Care
- Medical
Recent funding
Equity
Jan 2023
$3M
Team
Juran Kato
President and CEO
Lili Mao
Chief Science Officer and Co-Founder
Takako Naito
Research Alliance, Chief, Co-Founder
Makoto Shimazaki
Director